The US National Institutes of Health has launched two clinical trials to test a new long-acting form of HIV PrEP in cisgender women and people who inject drugs. These mid-stage studies will evaluate the safety and pharmacokinetics of lenacapavir, a bi-annual injectable antiretroviral drug.
NIH launches 2 clinical trials testing HIV drug on women, other minority groups yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
The National Institute of Health says they are seeking to now include underrepresented population groups for HIV studies, such as women, Black people, drug users and transgender people.